Emerging Therapies for Patients With HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer

In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the individualized care of patients with HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer, including:

• A brief overview of BTC and GEA
• Notable findings from a recent survey of healthcare professionals on BTC and GEA
• Case studies on recommended management of patients with BTC or GEA
• Emerging datasets of HER2-directed therapies in BTC and GEA affecting clinical practice
• Challenges faced by healthcare professionals in the management of patients with BTC and/or GEA
• Key ongoing trials of HER2-directed therapies in BTC and GEA

Presenters: 

Amit Mahipal, MD, MPH
Chief, GI Medical Oncology Program
Professor of Medicine
Ruth and Goodman Endowed Chair in GI Oncology
H Seidman Cancer Center and Case Western Reserve University
Cleveland, Ohio

Shubham Pant, MD
Professor
Department of Gastrointestinal Medical Oncology
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine
MD Anderson Cancer Center
Houston, Texas

Link to full program:
https://bit.ly/4ckcBrZ

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.